Αποτελέσματα Αναζήτησης
2 Δεκ 2023 · The Lancet Commission on women, power, and cancer 1 presents a comprehensive, global view of how the unique difficulties that women face can limit their ability to overcome the challenges that cancer presents, both for themselves and for society overall.
- Women, power, and cancer: A Lancet Commission
The Lancet Commission on women, power and cancer was created...
- A Lancet Commission on women and cancer - The Lancet
To advance an evidence-based, gendered approach to cancer...
- Women, power, and cancer: A Lancet Commission
26 Σεπ 2023 · The Lancet Commission on women, power and cancer was created to address urgent questions at the intersection of social inequality, cancer risk, and outcomes, and the status of women in society.
4 Ιουλ 2020 · To advance an evidence-based, gendered approach to cancer risk and cancer control, The Lancet Commission on women and cancer will address urgent questions at the intersection of social inequality, cancer risk, and outcomes, and the status of women in society. The Commission will comprise a multidisciplinary and diverse team with expertise in ...
15 Αυγ 2019 · Nature Reviews Cancer - In this Viewpoint article, we asked four female scientists to describe their experiences of gender representation during their scientific careers and to identify the ...
8 Μαρ 2021 · Women, particularly women of color, are still underrepresented in science and medical careers and face severe health disparities. To commemorate this day, we asked female cancer researchers and oncologists to talk about their work experiences and their efforts to improve equity, representation, and leadership.
15 Ιαν 2021 · Breast cancer is the most common cancer type among adolescents and young adults (AYAs) of age 15-39 years at diagnosis, accounting for 30% of cancers among AYA women.
Breast cancer (BC) is the most frequently diagnosed cancer in women worldwide with more than 2 million new cases in 2020. Its incidence and death rates have increased over the last three decades due to the change in risk factor profiles, better cancer registration, and cancer detection.
